A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : ANCA / antineutrophil cytoplasmic antibody

[Related PubMed/MEDLINE]
Total Number of Papers: 3342
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   ANCA  (>> Co-occurring Abbreviation)
Long Form:   antineutrophil cytoplasmic antibody
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2021 A Case of C-ANCA Positive Systematic Lupus Erythematous and ANCA-Associated Vasculitis Overlap Syndrome Superimposed by COVID-19: A Fatal Trio. ARDS, COVID-19, SLE
2021 A Case of Eosinophilic Granulomatosis with Polyangiitis Presenting with Central Retinal Artery Occlusion During Treatment with Anti-interleukin-5 Receptor Monoclonal Antibody. CRAO, EGPA, IL
2021 A Case of Microscopic Polyangiitis Presenting as Cranial Giant Cell Arteritis. GCA, MPA
2021 A Curious Case of Acute Glomerulonephritis - Staphylococcus vs Lupus: Case Report and Literature Review. ---
2021 A patient with sudden hearing loss induced by propylthiouracil. PTU
2021 A Rare Case of SARS-CoV-2-Induced Microscopic Polyangiitis. AKI, ANA, ANCA-MPO, SARS-CoV-2
2021 A Ruptured Jejunal Arterial Aneurysm in a Young Woman Undergoing Chronic Hemodialysis Due to Myeloperoxidase-antineutrophil Cytoplasmic Antibody-associated Vasculitis. ---
2021 Activated phosphoinositide 3-kinase delta syndrome misdiagnosed as anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report. APDS
2021 Acute glomerulonephritis in a hematopoietic blood stem cell donor. G-CSF, GN, PBSC
10  2021 Acute heart failure: on the track of a rare disease. ---
11  2021 Acute tubulointerstitial nephritis associated with antineutrophil cytoplasmic antibody following cimetidine treatment: a case report. ATIN, MPO-ANCA
12  2021 Advances in the genomics of ANCA-associated vasculitis-a view from East Asia. AAV, GWAS, MPA, MPO, PR3
13  2021 Age and Gender: Affecting the Positive Rates of Serum PAB and ANCA in Patients with Inflammatory Bowel Disease. ASCA, GAB, IBD
14  2021 Allograft failure in kidney transplant recipients who developed kidney failure secondary to ANCA-associated vasculitis. ---
15  2021 Altered follicular regulatory T (Tfr)- and helper T (Tfh)-cell subsets are associated with autoantibody levels in microscopic polyangiitis patients. HCs, MPA, MPO, Tfr
16  2021 An unusual precipitant of acute heart failure-ANCA-associated vasculitis in a patient with ischaemic cardiomyopathy: a case report. ADHF, CAD, CKD, DC, VT
17  2021 Analyses of registry data of patients with anti-GBM and antineutrophil cytoplasmatic antibody-associated (ANCA) vasculitis treated with or without therapeutic apheresis. AAV, TA
18  2021 ANCA (Antineutrophil Cytoplasmic Antibody)-Associated Pulmonary Vasculitis Causing Pulmonary Artery Stenosis: The Value of Multimodality Imaging in the Clinical Workup. ---
19  2021 ANCA associated glomerulonephritis in tuberculosis: a paradoxical reaction. TB
20  2021 ANCA Status or Clinical Phenotype - What Counts More? GPA, MPA, MPO, PR3
21  2021 ANCA Testing in Clinical Practice: From Implementation to Quality Control and Harmonization. AAV
22  2021 ANCA-Associated Glomerulonephritis and Anti-Phospholipid Syndrome in a Patient with SARS-CoV-2 Infection: Just a Coincidence? AKI, SARS-CoV-2
23  2021 ANCA-associated vasculitis after COVID-19. COVID-19, GN, SARS-CoV-2
24  2021 ANCA-associated vasculitis in a patient with enteropathic spondylarthritis: a case report and literature review. IBD, TNFi
25  2021 ANCA-associated Vasculitis Management in the United States: Data From the Rheumatology Informatics System for Effectiveness (RISE) Registry. CYC, RISE
26  2021 ANCA-associated vasculitis overlaps with systemic sclerosis: a case report and literature review. AAV, CRP, SRC, SSc
27  2021 ANCA-Associated Vasculitis: An Update. EGPA, GPA, MPA, MPO, PR3
28  2021 ANCA-negative microscopic polyangiitis with diffuse alveolar hemorrhage masquerading as congestive heart failure. AAV, ANA, MPA
29  2021 ANCA-Negative Pauci-Immune Necrotizing Glomerulonephritis: A Case Series and a New Clinical Classification. PING
30  2021 Anti-glomerular basement membrane disease (Goodpasture disease): From pathogenesis to plasma exchange to IdeS. GBM, IdeS
31  2021 Anti-neutrophil cytoplasm antibodies (ANCA) in autoimmune diseases: A matter of laboratory technique and clinical setting. ---
32  2021 Anti-Neutrophil Cytoplasmic Antibodies: To Care or Not to Care. AAV, ANA
33  2021 Anti-neutrophil cytoplasmic antibody specificity determines a different clinical subset in granulomatosis with polyangiitis. AAV, MPO-GPA, PR3-GPA
34  2021 Anti-Neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis and Malignancy: A Case of a Patient Diagnosed with Renal Failure and Pulmonary Carcinoma Concurrently. ---
35  2021 Antibody subtypes and titers predict clinical outcomes in ANCA-associated vasculitis. AAV, ESRD, MPO, PR3
36  2021 Antineutrophil cytoplasmic antibodies (ANCA) - their role in pathogenesis, diagnosis, and treatment monitoring of ANCA-associated vasculitis. MPO, NETs, PR3
37  2021 Antineutrophil cytoplasmic antibody (ANCA) vasculitis: pathophysiology, diagnosis, and the evolving treatment landscape. C5a, CD, PR3
38  2021 Antineutrophil Cytoplasmic Antibody Positivity Is Associated with Vascular Involvement in Behçet's Disease. BD, ICBD, ISG
39  2021 Antineutrophil cytoplasmic antibody profiles differ according to type of primary sclerosing cholangitis and autoimmune hepatitis. AIH, PSC
40  2021 Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis in a Case of Scleroderma After Recent Diagnosis With COVID-19. COVID-19, GN, SSc
41  2021 Antineutrophil Cytoplasmic Antibody-associated Vasculitis Management 2020: Where Are We Now? CYC, GC
42  2021 Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Update: Genetic Pathogenesis. EGPA, GPA, HLA, MPA
43  2021 Antineutrophil Cytoplasmic Antibody-Associated Vasculitis With Acute Kidney Injury: Short-Term Recovery Predicts Long-Term Outcome. AAV, AKI, ESRD, SCr
44  2021 Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis with Kidney Involvement in a Patient with AL Amyloidosis. ---
45  2021 Association Between Serum Alarmin Levels and Disease-specific Indices in Patients With Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis. BVAS, FFS, VDI
46  2021 Association of anti-neutrophil cytoplasmic antibody in ischemic stroke Egyptian patients with hepatitis C virus. c-ANCA, HCV, pANCA
47  2021 Association of venous thromboembolic events with skin, pulmonary and kidney involvement in ANCA-associated vasculitis: a multinational study. AAV, CIs, ORs, VTE
48  2021 Autoantibodies Against Lysosome Associated Membrane Protein-2 (LAMP-2) in Pediatric Chronic Primary Systemic Vasculitis. CRP, ESR, GFR, LAMP-2, MPO, PR3, pVAS
49  2021 Avacopan for the Treatment of ANCA-Associated Vasculitis. BVAS, CI
50  2021 Avacopan for the treatment of ANCA-associated vasculitis. GC
51  2021 Bowman's capsule rupture links glomerular damage to tubulointerstitial inflammation in ANCA-associated glomerulonephritis. BC, GN
52  2021 Case Report: Activating PIK3CD Mutation in Patients Presenting With Granulomatosis With Polyangiitis. APDS, GOF, GPA
53  2021 CCL2 produced by CD68+/CD163+ macrophages as a promising clinical biomarker of microscopic polyangiitis-interstitial lung disease. ILD, MPA
54  2021 Challenges in diagnosis of limited granulomatosis with polyangiitis. ACPA, GPA, RF
55  2021 Characterisation of an enhanced preclinical model of experimental MPO-ANCA autoimmune vasculitis. AAV, EAV, MPO, NTS
56  2021 Characteristics of and Prognosis for Facial Palsy in Patients With Otitis Media With ANCA-Associated Vasculitis (OMAAV). HB, OMAAV
57  2021 Characterization of a Rat Model of Myeloperoxidase-Anti-Neutrophil Cytoplasmic Antibody-Associated Crescentic Glomerulonephritis. GBM, GN, hMPO, MPO, NCAM, PECs
58  2021 Classification of ANCA-associated vasculitis: differences based on ANCA specificity and clinicopathologic phenotype. ---
59  2021 Clinical and pathological analysis of 101 cases of ANCA-associated vasculitic kidney injury. eGFR, ESR, Hb, non-C, SCr
60  2021 Clinical Manifestations and Long-Term Outcomes of Eosinophilic Granulomatosis With Polyangiitis in North America. EGPA, VDI
61  2021 Clinical significance of large unstained cell count in estimating the current activity of antineutrophil cytoplasmic antibody-associated vasculitis. AAV, BVAS, LUC
62  2021 Clinicopathological Analysis of 34 Cases of Primary Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Chinese Children. eGFR, ESRD, MPA, PVAS
63  2021 Clinicopathological characteristics and outcomes of anti-neutrophil cytoplasmic autoantibody-related renal vasculitis with hyperuricemia: a retrospective case-control study. ESRD
64  2021 Comparative efficacy and safety of rituximab, mycophenolate, and cyclophosphamide in active antineutrophil cytoplasmic antibody-associated vasculitis: A Bayesian network meta-analysis of randomized controlled trials. AAV, CrI, CYC, MMF, SAEs, SUCRA
65  2021 Comparison of outcomes using the rituximab originator MabThera with the biosimilar Truxima in patients with ANCA-associated vasculitis. AAV
66  2021 Complement Components C3 and C4 Indicate Vasculitis Manifestations to Distinct Renal Compartments in ANCA-Associated Glomerulonephritis. AAV, AKI, CKD, ESRD, GN, MPO, PR3
67  2021 Concurrent Anti-Glomerular Basement Membrane Antibody Disease and Membranous Nephropathy: A Case Series. GBM, MN, PLA2R
68  2021 Consensus Treatment Plans for Severe Pediatric Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. CARRA, CTPs, GPA
69  2021 Consideration of Therapeutic Plasma Exchange in Association With Inflammatory Lesions in ANCA-Associated Glomerulonephritis: A Real-World Retrospective Study From a Single Center. GN, GPA, MPA, PEX, RRT
70  2021 Correlation between serum cysteine-rich protein 61 and disease activity of antineutrophil cytoplasmic antibody-associated vasculitis. AAV, BVAS, Cyr61, IL, NF-kappaB, RR
71  2021 Cytomegalovirus-associated supraglottic mass in a patient on immunosuppressive therapy. CMV
72  2021 Differences between myeloperoxidase-antineutrophil cytoplasmic autoantibody (ANCA) and proteinase 3-ANCA associated vasculitis: A retrospective study from a single center in China. MPO, PR3
73  2021 Different Patterns of Kidney Fibrosis Are Indicative of Injury to Distinct Renal Compartments. CKD, ESKD, FAN, GN, IF/TA, IgAN, NTN, UUO
74  2021 Diffuse alveolar hemorrhage in a patient with anti-neutrophil cytoplasm antibody-associated vasculitis successfully treated with immunoadsorption combined with methylprednisolone. IA
75  2021 Distinguishing active from quiescent disease in ANCA-associated vasculitis using attenuated total reflection Fourier-transform infrared spectroscopy. ATR-FTIR
76  2021 Dose-dependent Pharmacological Response to Rituximab in the Treatment of Antineutrophil Cytoplasmic Antibody-associated Vasculitis. AAV, RTX
77  2021 Double-negative T cells are absolutely elevated in patients with antineutrophil cytoplasmic autoantibody-associated vasculitis. DN, HCs, IFN, IL, ROC
78  2021 Double-Positive Anti-GBM and ANCA-MPO Vasculitis Presenting With Crescentic Glomerulonephritis. GBM, RPGN
79  2021 Dynamic Changes in the Nasal Microbiome Associated With Disease Activity in Patients With Granulomatosis With Polyangiitis. GPA, PR3
80  2021 Effect of Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab on Remission Induction in ANCA-Associated Vasculitis: A Randomized Clinical Trial. ---
81  2021 Efficacy of plasma exchange for antineutrophil cytoplasmic antibody-associated systemic vasculitis: a systematic review and meta-analysis. AAV, AEs, CI, CR, EGPA, GPA, MPA, PE, RCTs, RR
82  2021 Eosinophilic Granulomatosis with Polyangiitis Presenting with Myocarditis as an Initial Symptom: A Case Report and Review of the Literature. EGPA
83  2021 Eosinophilic Granulomatosis with Polyangiitis: A Systematic Review and Meta-Analysis of Test Accuracy and Benefits and Harms of Common Treatments. AAV, EGPA, GPA, MPA, MPO, PICO
84  2021 Evolving Challenges in Diagnosis of Renal Vasculitis. ---
85  2021 Exploratory classification of clinical phenotypes in Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis using cluster analysis. CRP, ENT, SCr
86  2021 Extracorporeal Membrane Oxygenation Support for Antineutrophil Cytoplasmic Antibody-associated Vasculitides: An ELSO Registry Analysis. ECMO
87  2021 Fibrinogen to albumin ratio reflects the activity of antineutrophil cytoplasmic antibody-associated vasculitis. AAV, BVAS, CRP, ESR, FAR
88  2021 Fluorine (19F) MRI for Assessing Inflammatory Cells in the Kidney: Experimental Protocol. COST, PFCE
89  2021 From Kidney to Brain: An Uncommon Severe Relapse of Myeloperoxidase Anti-Neutrophil Cytoplasmic Antibody (MPO-ANCA) Vasculitis. CNS, ED, MPO, MPO-ANCA
90  2021 Gastrointestinal symptoms as first remarkable signs of ANCA-associated granulomatosis with polyangiitis: a case report and reviews. GPA
91  2021 Glomerular Immune Deposition in MPO-ANCA Associated Glomerulonephritis Is Associated With Poor Renal Survival. IC, IF, MPO, PI, sC3
92  2021 Glomerulonephritis Caused by Bartonella spp. Infective Endocarditis: The Difficulty and Importance of Differentiation from Anti-neutrophil Cytoplasmic Antibody-related Rapidly Progressive Glomerulonephritis. RPGN
93  2021 Granulomatosis with Polyangiitis: Recurrence or Treatment Consequences? AAV, GPA
94  2021 Highly Sensitive Flow Cytometric Detection of Residual B-Cells After Rituximab in Anti-Neutrophil Cytoplasmic Antibodies-Associated Vasculitis Patients. AAV, ASC, HSFC, MRA, PBMCs, PBs, PC, Pre-GC, RTX
95  2021 Histopathologic and clinicopathologic classifications of antineutrophil cytoplasmic antibody-associated glomerulonephritis: a validation study in a Korean cohort. aHR, CI, ESKD
96  2021 Hydralazine-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Asymptomatic and Renal-Restricted Presentation. ---
97  2021 Hypertrophic Pachymeningitis in Eosinophilic Granulomatosis with Polyangiitis. AAV, EGPA, HP
98  2021 Hypertrophic spinal pachymeningitis caused by ANCA-associated vasculitis revealed by 18F-FDG PET/CT: A case report. ---
99  2021 Identification of neutrophil β2-integrin LFA-1 as a potential mechanistic biomarker in ANCA-associated vasculitis via microarray and validation analyses. AAV, GSEA, HCs, HUVECs, ICAM-1, LFA-1
100  2021 IgA nephropathy in patients with serum anti-neutrophil cytoplasmic autoantibody (ANCA) positivity: case series. ---